/Companies

Skybound Medtech

Houston, US · Founded 2025 · Texas corporation

Find your way into Skybound Medtech

Sign up to see every warm intro you have to Skybound Medtech

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Skybound Medtech team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Skybound develops platform medical technologies targeting the physiological barriers to long-duration human spaceflight—such as bone loss, muscle atrophy, immune dysregulation, and radiation-induced damage—and applies the same technologies to major terrestrial health problems. Its focus areas include delaying and reversing age-related decline and chronic disease, delivering remote healthcare with minimal clinician supervision, and personalized real-time therapies.

Founders & leadership

MKMatthew Kuhn
Matthew KuhnFounderMatthew Kuhn is founder and CEO of Skybound Medtech, which develops medical technologies to address physiological challenges in spaceflight and terrestrial health conditions including aging and critical care. He holds named inventor credits on over 50 U.S. patents in cardiovascular, neurovascular, and surgical device domains.

Reported raises · per SEC filings

Form D private placements

$1.3M disclosed across 1 round · 2026

▶$1.3MraisedJul 2026 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew KuhnExecutive Officer
Offering amount
$1.3M
Amount sold
$1.3M
First sale
Jun 2026
Incorporated
Corporation, Texas, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Skybound Medtech do?
Skybound develops platform medical technologies targeting the physiological barriers to long-duration human spaceflight—such as bone loss, muscle atrophy, immune dysregulation, and radiation-induced damage—and applies the same technologies to major terrestrial health problems. Its focus areas include delaying and reversing age-related decline and chronic disease, delivering remote healthcare with minimal clinician supervision, and personalized real-time therapies.
How much funding has Skybound Medtech raised?
Skybound Medtech has disclosed $1.3M raised across 1 round.
Where is Skybound Medtech headquartered?
Skybound Medtech is headquartered in Houston, US.